Can fluid tracking prevent kidney damage in the ICU?
NCT ID NCT07338734
First seen Jan 18, 2026 · Last updated Jun 23, 2026 · Updated 23 times
Summary
This study will follow 120 critically ill adults in the ICU to see if the amount of fluid they receive in the first 48 hours is linked to developing acute kidney injury (AKI). Researchers will track fluids hourly and check kidney function for up to 7 days. The goal is to find patterns that could help doctors manage fluids better and reduce AKI risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could point toward better fluid management strategies to lower the risk of acute kidney injury in critically ill patients.
What could go wrong
This is an observational study, not a treatment trial. It only looks for links, so it cannot prove cause and effect. Results may not apply to all ICU patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.